DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,160 filers reported holding DANAHER CORPORATION in Q1 2024. The put-call ratio across all filers is 1.13 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $318,108 | -1.4% | 1,301 | +0.7% | 0.04% | -2.7% |
| Q1 2024 | $322,638 | +5.9% | 1,292 | -1.9% | 0.04% | -2.6% |
| Q4 2023 | $304,675 | +6.5% | 1,317 | 0.0% | 0.04% | -2.6% |
| Q3 2023 | $286,092 | -11.4% | 1,317 | -2.2% | 0.04% | -11.4% |
| Q2 2023 | $323,040 | +1.6% | 1,346 | +6.7% | 0.04% | -10.2% |
| Q1 2023 | $318,074 | -5.0% | 1,262 | 0.0% | 0.05% | -5.8% |
| Q4 2022 | $334,960 | +2.7% | 1,262 | 0.0% | 0.05% | -3.7% |
| Q3 2022 | $326,000 | +1.9% | 1,262 | 0.0% | 0.05% | +10.2% |
| Q2 2022 | $320,000 | -13.5% | 1,262 | 0.0% | 0.05% | -5.8% |
| Q1 2022 | $370,000 | -20.4% | 1,262 | -10.6% | 0.05% | -21.2% |
| Q4 2021 | $465,000 | +41.3% | 1,412 | +30.5% | 0.07% | +26.9% |
| Q3 2021 | $329,000 | +13.4% | 1,082 | 0.0% | 0.05% | +10.6% |
| Q2 2021 | $290,000 | +15.5% | 1,082 | -3.1% | 0.05% | +9.3% |
| Q1 2021 | $251,000 | +68.5% | 1,117 | +66.5% | 0.04% | +53.6% |
| Q4 2020 | $149,000 | – | 671 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
| Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
| Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
| Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
| CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
| Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
| Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
| BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
| Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |